NovellusDx competitors

NovellusDx Competitors include UNUM Therapeutics, Biotech Products Services and Research, Artios Pharma and Hemarina.
Add company...
NovellusDx
NovellusDx
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.
UNUM Therapeutics
UNUM Therapeutics
Cancer cell therapy company developing a platform to couple tumor-specific antibodies to the body’s own immune system.
Biotech Products Services and Research
Biotech Products Services and Research
Biotech Products Services and Research, Inc., a biotech company, discovers, develops, and dispatches cellular disease management protocols for the treatment of neurodegenerative, inflammatory, and autoimmune conditions for patients worldwide.
Artios Pharma
Artios Pharma
A new private company focused on developing novel cancer treatments targeting the DNA Damage Response
Hemarina
Hemarina
Hemarina is a biotechnology company centered on the research and development of marine oxygen carriers for therapeutic and industrial applications.
Founding Date
Founding Date
2012
Founding Date
2014
Founding Date
2011
Founding Date
2016
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Jerusalem, IL HQ
Locations
Cambridge, US HQ
Locations
Miami Beach, US HQ
Locations
Cambridgeshire, GB HQ
Locations
Morlaix, FR HQ
Employees
Employees
N/A
Employees
563% decrease
Employees
6
Employees
N/A
Employees
186
Twitter followers
Twitter followers
N/A
Twitter followers
687
Twitter followers
N/A
Twitter followers
134
Twitter followers
1.6 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$8.4m (FY, 2017)
Revenue (est.)
$569.8k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($25.5m) (FY, 2017)
Net income
($9.1m) (FY, 2017)
Net income
(£4.9m) (FY, 2017)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 6m (8 months ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 83.6m (4 months ago)
Latest funding round
$ 3.7m (over 8 years ago)
Total funding raised
Total funding raised
$ 34.5m
Total funding raised
$ 178.3m
Total funding raised
N/A
Total funding raised
$ 116.1m
Total funding raised
$ 4.8m
For sources of this data, please see the company profileDownload Excel

View company profiles

UNUM Therapeutics
HQ
Cambridge, US
Employees
56↓ 3% decrease

Cancer cell therapy company developing a platform to couple tumor-specific antibodies to the body’s own immune system.

View company
Biotech Products Services and Research
HQ
Miami Beach, US
Employees
6

Biotech Products Services and Research, Inc., a biotech company, discovers, develops, and dispatches cellular disease management protocols for the treatment of neurodegenerative, inflammatory, and autoimmune conditions for patients worldwide.

View company
Artios Pharma
HQ
Cambridgeshire, GB

A new private company focused on developing novel cancer treatments targeting the DNA Damage Response

View company
Hemarina
HQ
Morlaix, FR
Employees
186

Hemarina is a biotechnology company centered on the research and development of marine oxygen carriers for therapeutic and industrial applications.

View company